Loading clinical trials...
Loading clinical trials...
Introduction of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer. Influence of This New Operation Technique on Local Recurrence and Long-Time Survival. Retrospective Study: 1993-2001
Conditions
Interventions
conventional rectal surgery
total mesorectal excision
Locations
1
Switzerland
Dep. of visceral and transplant surgery, Bern University Hospital
Bern, Switzerland
Start Date
January 1, 1993
Primary Completion Date
December 1, 2001
Completion Date
December 1, 2001
Last Updated
May 29, 2009
NCT04929028
NCT04704661
NCT06696768
NCT05489211
NCT06625775
NCT04674267
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions